Literature DB >> 9836582

Regeneration of the ferrous heme of soluble guanylate cyclase from the nitric oxide complex: acceleration by thiols and oxyhemoglobin.

P E Brandish1, W Buechler, M A Marletta.   

Abstract

Soluble guanylate cyclase (sGC) catalyzes the conversion of GTP to cGMP and is activated several hundred-fold by binding of nitric oxide (*NO) to the heme prosthetic group. We have examined the stability of the nitrosyl-heme complex of sGC (*NO-sGC) at 37 degreesC in order to determine whether simple dissociation of *NO from sGC could account for the observed in vivo deactivation time. Recombinant sGC was purified from Sf9 cells coinfected with baculoviruses containing the cDNAs for the alpha1 and beta1 subunits of rat lung sGC. The purified protein contained a stoichiometric equivalent of ferrous high-spin heme. Characterization of the purified protein found it to be essentially identical to that purified from bovine lung. Ferrous-nitrosyl sGC prepared anaerobically and exchanged into aerobic buffer containing no reducing agents was essentially stable on ice and had a half-life of approximately 90 min at 37 degreesC. In the presence of thiols [DTT, glutathione (GSH), or L-cysteine], *NO was rapidly lost from sGC regenerating the ferrous high-spin form of the heme. The half-life of *NO-sGC in the presence of 1 mM GSH at 37 degreesC was 6.3 min. In the presence of oxyhemoglobin, the half-life was further reduced to 2.9 min. Although these rates are not fast enough to account for that observed in vivo, and thus probably involve additional agent(s), these data do imply a role for low molecular weight thiols, such as GSH, and oxyferrohemoproteins, such as oxymyoglobin, in the deactivation of sGC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9836582     DOI: 10.1021/bi9814989

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  30 in total

1.  Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses.

Authors:  T C Bellamy; J Wood; D A Goodwin; J Garthwaite
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  On the activation of soluble guanylyl cyclase by nitric oxide.

Authors:  Tomas C Bellamy; John Wood; John Garthwaite
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 3.  Soluble guanylate cyclases in the retina.

Authors:  Ari Sitaramayya
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 4.  The receptor-like properties of nitric oxide-activated soluble guanylyl cyclase in intact cells.

Authors:  Tomas C Bellamy; John Garthwaite
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 5.  Isoforms of NO-sensitive guanylyl cyclase.

Authors:  Michael Russwurm; Doris Koesling
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

6.  Mechanism of binding of NO to soluble guanylyl cyclase: implication for the second NO binding to the heme proximal site.

Authors:  Emil Martin; Vladimir Berka; Iraida Sharina; Ah-Lim Tsai
Journal:  Biochemistry       Date:  2012-03-19       Impact factor: 3.162

7.  Revisiting the kinetics of nitric oxide (NO) binding to soluble guanylate cyclase: the simple NO-binding model is incorrect.

Authors:  David P Ballou; Yunde Zhao; Philip E Brandish; Michael A Marletta
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-03       Impact factor: 11.205

8.  Dynamic ligand exchange in soluble guanylyl cyclase (sGC): implications for sGC regulation and desensitization.

Authors:  Ah-Lim Tsai; Vladimir Berka; Iraida Sharina; Emil Martin
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

Review 9.  The muscle fiber type-fiber size paradox: hypertrophy or oxidative metabolism?

Authors:  T van Wessel; A de Haan; W J van der Laarse; R T Jaspers
Journal:  Eur J Appl Physiol       Date:  2010-07-03       Impact factor: 3.078

10.  NO activation of guanylyl cyclase.

Authors:  Michael Russwurm; Doris Koesling
Journal:  EMBO J       Date:  2004-10-28       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.